Search for: "Astrazeneca"
Results 661 - 680
of 1,246
Sort by Relevance
|
Sort by Date
15 Nov 2011, 3:58 pm
Drug giants including Roche, Pfizer, and AstraZeneca have taken their own steps toward embracing stem-cell-based research. [read post]
31 Oct 2011, 4:58 am
When a plaintiff’s lawyer is considering filing dozens or hundreds of lawsuits against GlaxoSmithKline, or AstraZeneca, or Teva Pharmaceuticals, or Siemens Medical, or McNeil Laboratories, or Merck, or Wyeth — all of which have a significant presence in or around Philadelphia — the obvious choice is to file in the quicker venue with more experience and more resources to handle the cases. [read post]
28 Oct 2011, 4:35 pm
Although the "patent cliff" is bad news for major pharmaceutical manufacturers such as AstraZeneca, Pfizer, and Bristol-Myers Squibb/Sanofi Pharmaceuticals, many patients will finally be able afford the prescriptions they need to manage their conditions. [read post]
27 Oct 2011, 4:24 am
AstraZeneca paid $520 for Seroquel. [read post]
27 Oct 2011, 12:59 am
In WIPO Re:Search, Alnylam Pharmaceuticals, AstraZeneca, Eisai, GlaxoSmithKline, MSD1, Novartis, Pfizer, and Sanofi [not bad for a start -- the Kats think that this list will grow, given that membership is "open to all" (below] are collaborating with WIPO, BVGH, the U.S. [read post]
26 Oct 2011, 2:30 am
GlaxoSmithKline (Holman’s Biotech IP Blog) Femcon Fe (Norethindrone, Ethinyl estradiol) – US: Famy Care and Mylan settle Femcon Fe lawsuit with Warner Chilcott (Patent Circle) Fentanyl – EU: Agreement over pain killer a tender issue in Europe (IP Whiteboard) Quetiapine – Bulgaria: Quetiapine and Bulgaria’s transitional ruling: AstraZeneca v Bulgarian Patent Office (The SPC Blog) Thalomid (Thalidomide, Mephalan, Prednisone) – Australia: APO: No extension… [read post]
18 Oct 2011, 9:33 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011)? [read post]
18 Oct 2011, 8:17 am
Within the last five years alone, Pfizer, AstraZeneca, Boston Scientific, Eli Lilly, and Biovail paid a combined total of $4.3 billion to settle claims of unlawful marketing. [read post]
5 Oct 2011, 5:33 pm
San Diego - AstraZeneca appeared in front of the U.S. [read post]
3 Oct 2011, 8:01 pm
According to AZ: FDA has periodically required AstraZeneca to revise its label to include new information concerning the use of Seroquel. [read post]
3 Oct 2011, 5:20 am
Having briefly summarised Ranbaxy v AstraZeneca, Datacard Corporation v Eagle and Gedeon Richter v Bayer Schering Pharma AG, Mr Alexander stressed that the prior art status of commonly accessible documents marked confidential in LG Electronics v Sony was yet to be conclusively determined – "watch this space". [read post]
28 Sep 2011, 3:20 pm
The complaint was filed by Mary Mai Nguyen and Tuoc Duong on September 15 in Harris County, Texas against AstraZeneca. [read post]
27 Sep 2011, 12:38 pm
At AstraZeneca, Engelmann advised company leadership on a variety of legal and regulatory matters as well as defending federal and state investigations and patent challenges. [read post]
27 Sep 2011, 8:34 am
Good work by the folks at Pharmalot.Lawsuit was filed alleging that AstraZeneca is to blame for bone deterioration and bone fractures allegedly attributed to the Nexium acid reflux pill.Read more here. [read post]
26 Sep 2011, 7:05 am
AstraZeneca’s patent on the brand-name product expires on 09/26/11. [read post]
19 Sep 2011, 11:27 am
It was developed by Merck & Co. and is marketed worldwide as Prinivil or Tensopril and by AstraZeneca as Zestril. [read post]
18 Sep 2011, 5:57 pm
AstraZeneca cut speaker spending from about $22.8 million in the first half of 2010 to about $9.2 million in the second half. [read post]
1 Sep 2011, 8:39 am
Some of the most common brands in this category of drugs include Abbott Laboratories’ Lupron, Astrazeneca’s Zoladex, and Pfizer’s Synarel. [read post]
1 Sep 2011, 6:14 am
After more than four years of litigation, AstraZeneca has agreed to pay $2.5 million to settle State of Idaho v. [read post]
25 Aug 2011, 4:15 pm
Marketed by AstraZeneca and Takeda, Candesartan cilexetil is indicated for the treatment of hypertension and heart failure, with sales of US $1.5bn in 2010. [read post]
